c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma.
Luo H, Chen Z, Wang S, Zhang R, Qiu W, Zhao L, Peng C, Xu R, Chen W, Wang HW, Chen Y, Yang J, Zhang X, Zhang S, Chen D, Wu W, Zhao C, Cheng G, Jiang T, Lu D, You Y, Liu N, Wang H.
Luo H, et al.
Brain. 2015 Dec;138(Pt 12):3654-72. doi: 10.1093/brain/awv287. Epub 2015 Oct 8.
Brain. 2015.
PMID: 26450587